These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 18649741)
1. 25-Hydroxyvitamin D-1 alpha-hydroxylase (CYP27B1) is a new class of tumor suppressor in the prostate. Chen TC Anticancer Res; 2008; 28(4A):2015-7. PubMed ID: 18649741 [TBL] [Abstract][Full Text] [Related]
2. Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. Chen TC; Wang L; Whitlatch LW; Flanagan JN; Holick MF J Cell Biochem; 2003 Feb; 88(2):315-22. PubMed ID: 12520532 [TBL] [Abstract][Full Text] [Related]
3. Regulation of 25-hydroxyvitamin D-1alpha-hydroxylase by epidermal growth factor in prostate cells. Wang L; Flanagan JN; Whitlatch LW; Jamieson DP; Holick MF; Chen TC J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):127-30. PubMed ID: 15225759 [TBL] [Abstract][Full Text] [Related]
4. Prostate 25-hydroxyvitamin D-1alpha-hydroxylase is up-regulated by suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor. Wang L; Persons KS; Jamieson D; Flanagan JN; Hsu HH; Holick MF; Luo Z; Sakaki T; Urushino N; Faller DV; Chen TC Anticancer Res; 2008; 28(4A):2009-13. PubMed ID: 18649740 [TBL] [Abstract][Full Text] [Related]
5. 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. Whitlatch LW; Young MV; Schwartz GG; Flanagan JN; Burnstein KL; Lokeshwar BL; Rich ES; Holick MF; Chen TC J Steroid Biochem Mol Biol; 2002 Jun; 81(2):135-40. PubMed ID: 12137802 [TBL] [Abstract][Full Text] [Related]
6. The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D. Young MV; Schwartz GG; Wang L; Jamieson DP; Whitlatch LW; Flanagan JN; Lokeshwar BL; Holick MF; Chen TC Carcinogenesis; 2004 Jun; 25(6):967-71. PubMed ID: 14729578 [TBL] [Abstract][Full Text] [Related]
7. The roles of cytochrome P450 enzymes in prostate cancer development and treatment. Chen TC; Sakaki T; Yamamoto K; Kittaka A Anticancer Res; 2012 Jan; 32(1):291-8. PubMed ID: 22213318 [TBL] [Abstract][Full Text] [Related]
8. Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissue. Friedrich M; Diesing D; Cordes T; Fischer D; Becker S; Chen TC; Flanagan JN; Tangpricha V; Gherson I; Holick MF; Reichrath J Anticancer Res; 2006; 26(4A):2615-20. PubMed ID: 16886671 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells. Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637 [TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanism(s) Involved in 25-Hydroxyvitamin D's Antiproliferative Effects in CYP27B1-transfected LNCaP Cells. Banks M; Holick MF Anticancer Res; 2015 Jul; 35(7):3773-9. PubMed ID: 26124321 [TBL] [Abstract][Full Text] [Related]
11. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Bareis P; Bises G; Bischof MG; Cross HS; Peterlik M Biochem Biophys Res Commun; 2001 Jul; 285(4):1012-7. PubMed ID: 11467853 [TBL] [Abstract][Full Text] [Related]
12. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. St-Arnaud R; Messerlian S; Moir JM; Omdahl JL; Glorieux FH J Bone Miner Res; 1997 Oct; 12(10):1552-9. PubMed ID: 9333115 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of vitamin D hydroxylase expression and activity in normal and malignant human prostate cells. Khorchide M; Lechner D; Cross HS J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):167-72. PubMed ID: 15860259 [TBL] [Abstract][Full Text] [Related]
14. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3). Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461 [TBL] [Abstract][Full Text] [Related]
15. Antenatal endotoxin disrupts lung vitamin D receptor and 25-hydroxyvitamin D 1α-hydroxylase expression in the developing rat. Mandell E; Seedorf GJ; Ryan S; Gien J; Cramer SD; Abman SH Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(9):L1018-26. PubMed ID: 26342089 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the 25-hydroxyvitamin D-1alpha-hydroxylase gene and its splice variant. Flanagan JN; Wang L; Tangpricha V; Reichrath J; Chen TC; Holick MF Recent Results Cancer Res; 2003; 164():157-67. PubMed ID: 12899521 [TBL] [Abstract][Full Text] [Related]
17. Expression of 25 hydroxyvitamin D3-1alpha-hydroxylase in human endometrial tissue. Becker S; Cordes T; Diesing D; Diedrich K; Friedrich M J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):771-5. PubMed ID: 17236759 [TBL] [Abstract][Full Text] [Related]
18. 25-Hydroxyvitamin D3 1alpha-hydroxylase splice variants in breast cell lines MCF-7 and MCF-10. Fischer D; Seifert M; Becker S; Ludders D; Cordes T; Reichrath J; Friedrich M Cancer Genomics Proteomics; 2007; 4(4):295-300. PubMed ID: 17878529 [TBL] [Abstract][Full Text] [Related]
20. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. Viganò P; Lattuada D; Mangioni S; Ermellino L; Vignali M; Caporizzo E; Panina-Bordignon P; Besozzi M; Di Blasio AM J Mol Endocrinol; 2006 Jun; 36(3):415-24. PubMed ID: 16720713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]